Sugarloaf Wealth Management’s Alterity Therapeutics ATHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $109 | Hold |
33
| – | – | ﹤0.01% | 677 |
|
|
2024
Q3 | $43 | Hold |
33
| – | – | ﹤0.01% | 671 |
|
|
2024
Q2 | $60 | Hold |
33
| – | – | ﹤0.01% | 659 |
|
|
2024
Q1 | $68 | Hold |
33
| – | – | ﹤0.01% | 670 |
|
|
2023
Q4 | $82 | Hold |
33
| – | – | ﹤0.01% | 676 |
|
|
2023
Q3 | $82 | Hold |
33
| – | – | ﹤0.01% | 672 |
|
|
2023
Q2 | $92 | Hold |
33
| – | – | ﹤0.01% | 681 |
|
|
2023
Q1 | $92 | Hold |
33
| – | – | ﹤0.01% | 688 |
|
|
2022
Q4 | $116 | Hold |
33
| – | – | ﹤0.01% | 765 |
|
|
2022
Q3 | $1K | Hold |
33
| – | – | ﹤0.01% | 729 |
|
|
2022
Q2 | $0 | Hold |
33
| – | – | ﹤0.01% | 764 |
|
|
2022
Q1 | $0 | Hold |
33
| – | – | ﹤0.01% | 705 |
|
|
2021
Q4 | $0 | Hold |
33
| – | – | ﹤0.01% | 737 |
|
|
2021
Q3 | $0 | Hold |
33
| – | – | ﹤0.01% | 746 |
|
|
2021
Q2 | $0 | Hold |
33
| – | – | ﹤0.01% | 740 |
|
|
2021
Q1 | $0 | Hold |
33
| – | – | ﹤0.01% | 738 |
|
|
2020
Q4 | $0 | Hold |
33
| – | – | ﹤0.01% | 709 |
|
|
2020
Q3 | $1K | Hold |
33
| – | – | ﹤0.01% | 630 |
|
|
2020
Q2 | $0 | Hold |
33
| – | – | ﹤0.01% | 671 |
|
|
2020
Q1 | $0 | Hold |
33
| – | – | ﹤0.01% | 682 |
|
|
2019
Q4 | $0 | Buy |
+33
| New | – | ﹤0.01% | 693 |
|